The measurement of DA receptor and SRL response genes in NF-PitNETs provides interesting information that could be useful in the case that a pharmacological treatment is considered in this type of pituitary tumors (35); thus, it would be recommendable to perform such studies rather than initiating a blind course of treatment with unpredictable results. This evidence concerns the gene SRL and pituitary tumor.